BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Louie AD, Huntington K, Carlsen L, Zhou L, El-Deiry WS. Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics. Front Pharmacol 2021;12:747194. [PMID: 34737704 DOI: 10.3389/fphar.2021.747194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Seyhan AA, Carini C. Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates. Int J Mol Sci 2022;24. [PMID: 36613491 DOI: 10.3390/ijms24010041] [Reference Citation Analysis]
2 Sarvari P, Sarvari P, Ramírez-díaz I, Mahjoubi F, Rubio K. Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer. IJMS 2022;23:9521. [DOI: 10.3390/ijms23179521] [Reference Citation Analysis]
3 Mao XY, Perez-Losada J, Abad M, Rodríguez-González M, Rodríguez CA, Mao JH, Chang H. iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers. World J Clin Oncol 2022; 13(7): 616-629 [DOI: 10.5306/wjco.v13.i7.616] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pu J, Yu H, Guo Y. A Novel Strategy to Identify Prognosis-Relevant Gene Sets in Cancers. Genes 2022;13:862. [DOI: 10.3390/genes13050862] [Reference Citation Analysis]
5 Firdous S, Srivastava SK, Saha S. Cancer Biomarkers in the Era of Systems Biology. Systems Biomedicine Approaches in Cancer Research 2022. [DOI: 10.1007/978-981-19-1953-4_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]